Παρακολούθηση
Clayton Yates
Clayton Yates
Johns Hopkins School of Medicine
Η διεύθυνση ηλεκτρονικού ταχυδρομείου έχει επαληθευτεί στον τομέα jhmi.edu
Τίτλος
Παρατίθεται από
Παρατίθεται από
Έτος
E-cadherin as an indicator of mesenchymal to epithelial reverting transitions during the metastatic seeding of disseminated carcinomas
A Wells, C Yates, CR Shepard
Clinical & experimental metastasis 25, 621-628, 2008
4342008
Diverse roles of mitochondria in immune responses: novel insights into immuno-metabolism
A Angajala, S Lim, JB Phillips, JH Kim, C Yates, Z You, M Tan
Frontiers in immunology 9, 1605, 2018
4222018
Mannose receptor (CD206) activation in tumor-associated macrophages enhances adaptive and innate antitumor immune responses
JM Jaynes, R Sable, M Ronzetti, W Bautista, Z Knotts, ...
Science translational medicine 12 (530), eaax6337, 2020
2972020
Co-culturing human prostate carcinoma cells with hepatocytes leads to increased expression of E-cadherin
CC Yates, CR Shepard, DB Stolz, A Wells
British journal of cancer 96 (8), 1246-1252, 2007
1742007
Snail promotes epithelial mesenchymal transition in breast cancer cells in part via activation of nuclear ERK2
BN Smith, LJ Burton, V Henderson, DD Randle, DJ Morton, BA Smith, ...
PloS one 9 (8), e104987, 2014
1502014
Polyphenol-rich sweet potato greens extract inhibits proliferation and induces apoptosis in prostate cancer cells in vitro and in vivo
P Karna, SR Gundala, MV Gupta, SA Shamsi, RD Pace, C Yates, ...
Carcinogenesis 32 (12), 1872-1880, 2011
1142011
Enhanced noscapine delivery using uPAR-targeted optical-MR imaging trackable nanoparticles for prostate cancer therapy
MO Abdalla, P Karna, HK Sajja, H Mao, C Yates, T Turner, R Aneja
Journal of controlled release 149 (3), 314-322, 2011
1062011
Anti-PD-1/L1 lead-in before MAPK inhibitor combination maximizes antitumor immunity and efficacy
Y Wang, S Liu, Z Yang, AP Algazi, SH Lomeli, Y Wang, M Othus, A Hong, ...
Cancer Cell 39 (10), 1375-1387. e6, 2021
1032021
Novel three‐dimensional organotypic liver bioreactor to directly visualize early events in metastatic progression
C Yates, CR Shepard, G Papworth, A Dash, DB Stolz, S Tannenbaum, ...
Advances in cancer research 97, 225-246, 2007
972007
African ancestry–associated gene expression profiles in triple-negative breast cancer underlie altered tumor biology and clinical outcome in women of African descent
R Martini, P Delpe, TR Chu, K Arora, B Lord, A Verma, D Bedi, B Karanam, ...
Cancer discovery 12 (11), 2530-2551, 2022
872022
Panepoxydone targets NF-kB and FOXM1 to inhibit proliferation, induce apoptosis and reverse epithelial to mesenchymal transition in breast cancer
R Arora, C Yates, BD Gary, S McClellan, M Tan, Y Xi, E Reed, GA Piazza, ...
PLoS One 9 (6), e98370, 2014
872014
Nuclear Kaiso indicates aggressive prostate cancers and promotes migration and invasiveness of prostate cancer cells
J Jones, H Wang, J Zhou, S Hardy, T Turner, D Austin, Q He, A Wells, ...
The American journal of pathology 181 (5), 1836-1846, 2012
792012
Inhibition of the Warburg effect with a natural compound reveals a novel measurement for determining the metastatic potential of breast cancers
R Arora, D Schmitt, B Karanam, M Tan, C Yates, W Dean-Colomb
Oncotarget 6 (2), 662, 2015
752015
MicroRNA profiling of novel African American and Caucasian Prostate Cancer cell lines reveals a reciprocal regulatory relationship of miR-152 and DNA methyltranferase 1
SC Theodore, M Davis, F Zhao, H Wang, D Chen, J Rhim, ...
Oncotarget 5 (11), 3512, 2014
742014
AR negative triple negative or “quadruple negative” breast cancers in African American women have an enriched basal and immune signature
M Davis, S Tripathi, R Hughley, Q He, S Bae, B Karanam, R Martini, ...
PloS one 13 (6), e0196909, 2018
712018
Double-receptor-targeting multifunctional iron oxide nanoparticles drug delivery system for the treatment and imaging of prostate cancer
MSU Ahmed, AB Salam, C Yates, K Willian, J Jaynes, T Turner, ...
International journal of nanomedicine, 6973-6984, 2017
702017
Clinical and biological significance of KISS1 expression in prostate cancer
H Wang, J Jones, T Turner, QP He, S Hardy, WE Grizzle, DR Welch, ...
The American journal of pathology 180 (3), 1170-1178, 2012
662012
Atypical Chemokine Receptor 1 (DARC/ACKR1) in Breast Tumors Is Associated with Survival, Circulating Chemokines, Tumor-Infiltrating Immune Cells, and …
BD Jenkins, RN Martini, R Hire, A Brown, B Bennett, I Brown, EW Howerth, ...
Cancer epidemiology, biomarkers & prevention 28 (4), 690-700, 2019
632019
Kaiso, a transcriptional repressor, promotes cell migration and invasion of prostate cancer cells through regulation of miR-31 expression
H Wang, W Liu, SN Black, O Turner, JM Daniel, W Dean-Colomb, QP He, ...
Oncotarget 7 (5), 5677, 2015
592015
Nuclear localization of Kaiso promotes the poorly differentiated phenotype and EMT in infiltrating ductal carcinomas
J Jones, H Wang, B Karanam, S Theodore, W Dean-Colomb, DR Welch, ...
Clinical & experimental metastasis 31, 497-510, 2014
582014
Δεν είναι δυνατή η εκτέλεση της ενέργειας από το σύστημα αυτή τη στιγμή. Προσπαθήστε ξανά αργότερα.
Άρθρα 1–20